These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35328032)

  • 21. A novel OPA1 mutation causing variable age of onset autosomal dominant optic atrophy plus in an Australian family.
    Ahmad KE; Davis RL; Sue CM
    J Neurol; 2015 Oct; 262(10):2323-8. PubMed ID: 26194196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A splice site mutation in the murine Opa1 gene features pathology of autosomal dominant optic atrophy.
    Alavi MV; Bette S; Schimpf S; Schuettauf F; Schraermeyer U; Wehrl HF; Ruttiger L; Beck SC; Tonagel F; Pichler BJ; Knipper M; Peters T; Laufs J; Wissinger B
    Brain; 2007 Apr; 130(Pt 4):1029-42. PubMed ID: 17314202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondrial dysfunction in an Opa1(Q285STOP) mouse model of dominant optic atrophy results from Opa1 haploinsufficiency.
    Kushnareva Y; Seong Y; Andreyev AY; Kuwana T; Kiosses WB; Votruba M; Newmeyer DD
    Cell Death Dis; 2016 Jul; 7(7):e2309. PubMed ID: 27468686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation survey of the optic atrophy 1 gene in 193 Chinese families with suspected hereditary optic neuropathy.
    Chen Y; Jia X; Wang P; Xiao X; Li S; Guo X; Zhang Q
    Mol Vis; 2013; 19():292-302. PubMed ID: 23401657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of opa1 isoforms expression and apoptosis regulation in autosomal dominant optic atrophy (ADOA) patients with mutations in the opa1 gene.
    Formichi P; Radi E; Giorgi E; Gallus GN; Brunetti J; Battisti C; Rufa A; Dotti MT; Franceschini R; Bracci L; Federico A
    J Neurol Sci; 2015 Apr; 351(1-2):99-108. PubMed ID: 25796301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation spectrum and splicing variants in the OPA1 gene.
    Delettre C; Griffoin JM; Kaplan J; Dollfus H; Lorenz B; Faivre L; Lenaers G; Belenguer P; Hamel CP
    Hum Genet; 2001 Dec; 109(6):584-91. PubMed ID: 11810270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Creation of an Isogenic Human iPSC-Based RGC Model of Dominant Optic Atrophy Harboring the Pathogenic Variant c.1861C>T (p.Gln621Ter) in the
    García-López M; Jiménez-Vicente L; González-Jabardo R; Dorado H; Gómez-Manjón I; Martín MÁ; Ayuso C; Arenas J; Gallardo ME
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autosomal dominant optic atrophy caused by six novel pathogenic OPA1 variants and genotype-phenotype correlation analysis.
    Han J; Li Y; You Y; Fan K; Lei B
    BMC Ophthalmol; 2022 Jul; 22(1):322. PubMed ID: 35883160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic stroke in a patient with bi-allelic OPA1 mutations.
    Zerem A; Yosovich K; Rappaport YC; Libzon S; Blumkin L; Ben-Sira L; Lev D; Lerman-Sagie T
    Metab Brain Dis; 2019 Aug; 34(4):1043-1048. PubMed ID: 30972688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of OPA1 mutations on mitochondrial morphology and apoptosis: relevance to ADOA pathogenesis.
    Olichon A; Landes T; Arnauné-Pelloquin L; Emorine LJ; Mils V; Guichet A; Delettre C; Hamel C; Amati-Bonneau P; Bonneau D; Reynier P; Lenaers G; Belenguer P
    J Cell Physiol; 2007 May; 211(2):423-30. PubMed ID: 17167772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondrial DNA content is decreased in autosomal dominant optic atrophy.
    Kim JY; Hwang JM; Ko HS; Seong MW; Park BJ; Park SS
    Neurology; 2005 Mar; 64(6):966-72. PubMed ID: 15781809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A recurrent deletion mutation in OPA1 causes autosomal dominant optic atrophy in a Chinese family.
    Zhang L; Shi W; Song L; Zhang X; Cheng L; Wang Y; Ge X; Li W; Zhang W; Min Q; Jin ZB; Qu J; Gu F
    Sci Rep; 2014 Nov; 4():6936. PubMed ID: 25374051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defective mitochondrial adenosine triphosphate production in skeletal muscle from patients with dominant optic atrophy due to OPA1 mutations.
    Lodi R; Tonon C; Valentino ML; Manners D; Testa C; Malucelli E; La Morgia C; Barboni P; Carbonelli M; Schimpf S; Wissinger B; Zeviani M; Baruzzi A; Liguori R; Barbiroli B; Carelli V
    Arch Neurol; 2011 Jan; 68(1):67-73. PubMed ID: 20837821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel mutations of the OPA1 gene in Chinese dominant optic atrophy.
    Yen MY; Wang AG; Lin YC; Fann MJ; Hsiao KJ
    Ophthalmology; 2010 Feb; 117(2):392-6.e1. PubMed ID: 19969356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First submicroscopic inversion of the OPA1 gene identified in dominant optic atrophy - a case report.
    Weisschuh N; Mazzola P; Heinrich T; Haack T; Wissinger B; Tonagel F; Kelbsch C
    BMC Med Genet; 2020 Nov; 21(1):236. PubMed ID: 33243194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. OPA1-associated disorders: phenotypes and pathophysiology.
    Amati-Bonneau P; Milea D; Bonneau D; Chevrollier A; Ferré M; Guillet V; Gueguen N; Loiseau D; de Crescenzo MA; Verny C; Procaccio V; Lenaers G; Reynier P
    Int J Biochem Cell Biol; 2009 Oct; 41(10):1855-65. PubMed ID: 19389487
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Cartes-Saavedra B; Lagos D; Macuada J; Arancibia D; Burté F; Sjöberg-Herrera MK; Andrés ME; Horvath R; Yu-Wai-Man P; Hajnóczky G; Eisner V
    Proc Natl Acad Sci U S A; 2023 Mar; 120(12):e2207471120. PubMed ID: 36927155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutation spectrum of the OPA1 gene in a large cohort of patients with suspected dominant optic atrophy: Identification and classification of 48 novel variants.
    Weisschuh N; Schimpf-Linzenbold S; Mazzola P; Kieninger S; Xiao T; Kellner U; Neuhann T; Kelbsch C; Tonagel F; Wilhelm H; Kohl S; Wissinger B
    PLoS One; 2021; 16(7):e0253987. PubMed ID: 34242285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of inner retinal thickness in patients with autosomal dominant optic atrophy associated with OPA1 mutations.
    Ito Y; Nakamura M; Yamakoshi T; Lin J; Yatsuya H; Terasaki H
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4079-86. PubMed ID: 17724190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterozygous type 1 Autosomal Dominant Optic Atrophy (ADOA) with OPA1 c.1936-2A>G genetic variant.
    Mozo-Cuadrado M; Tabuenca-Del Barrio L; Belzunce-Manterola A; Rodríguez-Ulecia I; Morales Garófalo LM
    J Fr Ophtalmol; 2020 Mar; 43(3):e107-e108. PubMed ID: 31973973
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.